| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2268069A1 Diagnostic detection of nucleic acids |
| 04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | CA2268004A1 Candida utilis transformation system |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267648A1 Detection and identification of non-polio enteroviruses |
| 04/09/1998 | CA2267645A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | CA2267641A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | CA2267214A1 Multiplex polynucleotide capture methods and compositions |
| 04/09/1998 | CA2267205A1 Preparation of d-amino acids by direct fermentative means |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2267181A1 Vertebrate smoothened proteins |
| 04/09/1998 | CA2267178A1 Orpinomyces cellulases and coding sequences |
| 04/09/1998 | CA2267138A1 Compositions and methods for the identification and treatment of patients at risk for heart failure |
| 04/09/1998 | CA2267121A1 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2267092A1 Mammalian chemokines |
| 04/09/1998 | CA2267078A1 Fungal lichenase and coding sequences |
| 04/09/1998 | CA2267074A1 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium and rosa to control ethylene levels in geraniums and roses |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2266413A1 Elongin a and c functional domains |
| 04/09/1998 | CA2266327A1 Novel receptor that causes cell death |
| 04/09/1998 | CA2265514A1 Encapsulation of polypeptides within the starch matrix |
| 04/09/1998 | CA2265466A1 Human sulfonylurea receptor surh |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2237940A1 Method for obtaining microorganisms capable of producing antitumor molecules |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/08/1998 | EP0834740A1 Anti-glu17-osteocalcin antibody |
| 04/08/1998 | EP0834572A2 Alpha, gamma-diaminobutyric acid (DAB) containing oligopeptide derivatives |
| 04/08/1998 | EP0834571A1 Thermostable nucleic acid polymerase from Thermococcus gorgonarius |
| 04/08/1998 | EP0834570A1 Thermostable nucleic acid polymerase from Thermococcus gorgonarius |
| 04/08/1998 | EP0834569A1 Thermostable DNA polymerase from carboxydothermus hydrogenoformans |
| 04/08/1998 | EP0834568A2 Novel saliva binding protein |
| 04/08/1998 | EP0834567A2 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/08/1998 | EP0834566A2 Cotton plant gene |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834564A2 A mouse genomic clone of the CC-CKR5 receptor |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834562A1 Polypetide exhibiting calpain inhibition activity and method for the preparation thereof |
| 04/08/1998 | EP0834561A1 A gene related to migraine in man |
| 04/08/1998 | EP0834560A1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof |
| 04/08/1998 | EP0834558A2 Indoleacetaldehyde oxidase gene derived from plant and utilization thereof |
| 04/08/1998 | EP0834557A1 Monoclonal antibodies to detergents and their degradation products, and their use in immunoassays |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833947A1 Variant presenilin-2 genes |
| 04/08/1998 | EP0833946A1 Method and apparatus for determining a mutation |
| 04/08/1998 | EP0833944A1 Nucleic acid ligands that bind to and inhibit dna polymerases |
| 04/08/1998 | EP0833943A1 Method for identifying secretory genes in helicobacter pylori |
| 04/08/1998 | EP0833942A2 Process for the transcriptionless amplification of nucleic acids |
| 04/08/1998 | EP0833941A1 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 04/08/1998 | EP0833940A1 Encoded reaction cassette |
| 04/08/1998 | EP0833935A1 Cell line producing analgesic compounds for treating pain |
| 04/08/1998 | EP0833934A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/08/1998 | EP0833933A1 A method for producing influenza hemagglutinin multivalent vaccines |
| 04/08/1998 | EP0833932A2 Use of ovary-tissue transcriptional factors |
| 04/08/1998 | EP0833931A1 Bacillus strain and sporulation assay method |
| 04/08/1998 | EP0833930A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 04/08/1998 | EP0833929A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 04/08/1998 | EP0833928A1 Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof |
| 04/08/1998 | EP0833927A1 Gene encoding alkaline liquefying alpha-amylase |
| 04/08/1998 | EP0833926A1 Chondroitinase production in recombinant proteus vulgaris strains |
| 04/08/1998 | EP0833925A1 Diagnostic test for equine arteritis virus mediated disease |
| 04/08/1998 | EP0833924A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 04/08/1998 | EP0833923A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 04/08/1998 | EP0833922A1 A novel method to isolate mutants and to clone the complementing gene |
| 04/08/1998 | EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY |
| 04/08/1998 | EP0833920A2 Transferrin receptor genes |
| 04/08/1998 | EP0833919A1 Type f botulinum toxin and use thereof |
| 04/08/1998 | EP0833918A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |
| 04/08/1998 | EP0833917A2 Malarial pre-erythrocytic stage polypeptide molecules |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833915A1 Plant regulatory proteins iii |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833913A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 04/08/1998 | EP0833912A1 Novel tgf-beta like cytokine |
| 04/08/1998 | EP0833911A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 04/08/1998 | EP0833910A1 Cytoplasmic modulators of integrin regulation/signaling |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
| 04/08/1998 | EP0833908A1 Human homolog of the mouse rab18 gene |
| 04/08/1998 | EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
| 04/08/1998 | EP0833905A1 p-53 BINDING PROTEIN CALLED Mdmx AND ENCODING SEQUENCES FOR SAID PROTEIN |
| 04/08/1998 | EP0833904A1 Fibroblast growth factor-14 |
| 04/08/1998 | EP0833903A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 04/08/1998 | EP0833902A2 Oligonucleotides specific for hepatitis c virus |
| 04/08/1998 | EP0833901A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 04/08/1998 | EP0833900A1 Method of making herpes simplex type 1 mutants and mutants so produced |
| 04/08/1998 | EP0833899A1 Cis-9,10-octadecenoamidase |
| 04/08/1998 | EP0833898A1 A process for producing trypsin (trypsinogen) |
| 04/08/1998 | EP0833897A2 Prothrombin derivatives |
| 04/08/1998 | EP0833896A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 04/08/1998 | EP0833895A1 Immortalized retinal cell lines and their application |
| 04/08/1998 | EP0833894A1 Rapamcycin-based regulation of biological events |
| 04/08/1998 | EP0833892A1 Human hepatoma-derived growth factor-2 |
| 04/08/1998 | EP0833890A1 Coanda effect gene delivery instrument and method of use |